Like spring, summer, and fall, the winter flu season is a predictable feature of people’s lives around the world. While it typically means a few days off from work for adults, influenza can be a cause of death in the elderly and small children if they are unprotected by vaccination.
Work at CDDEP has focused on the impact of influenza vaccinations both on preventing the flu but also on secondary bacterial infections that may then need a course of antibiotic treatment. We have examined incentives for countries to look for and report outbreaks of novel influenza strains and the design of international mechanisms to encourage faster reporting.
CDDEP researchers have also developed a mathematical framework to estimate the value of investing in developing and conserving an antibiotic to mitigate the burden of bacterial infections caused by resistant Staphylococcus aureus during a pandemic influenza outbreak. In the event of a significant influenza pandemic, secondary infections caused by prevalent pan-drug resistant bacteria could be catastrophic. Effective antibiotics in the future are indispensable in the case of an influenza pandemic.